BusinessBioNtech, Pfizer files complaint against CureVac in U.S. over COVID-19 Vaccine patent claims Pavan Naidu • Jul 26, 2022
Web & Social MediaBioNTech claims it will know in two weeks whether the COVID-19 vaccine it developed with Pfizer is effective against the new B.1.1.529 variant strain that is quickly spreading in southern Africa Team Tech Outlook • Nov 26, 2021
